PHM7 Stock Overview
Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 1/6 |
Past Performance | 5/6 |
Financial Health | 2/6 |
Dividends | 6/6 |
Altria Group, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$38.69 |
52 Week High | US$43.59 |
52 Week Low | US$36.10 |
Beta | 0.70 |
1 Month Change | -5.69% |
3 Month Change | 4.72% |
1 Year Change | -7.54% |
3 Year Change | -2.19% |
5 Year Change | -16.63% |
Change since IPO | -25.75% |
Recent News & Updates
Recent updates
Shareholder Returns
PHM7 | DE Tobacco | DE Market | |
---|---|---|---|
7D | 0.09% | 0.2% | -1.5% |
1Y | -7.5% | -18.5% | 0.9% |
Return vs Industry: PHM7 exceeded the German Tobacco industry which returned -19.4% over the past year.
Return vs Market: PHM7 underperformed the German Market which returned -0.4% over the past year.
Price Volatility
PHM7 volatility | |
---|---|
PHM7 Average Weekly Movement | 2.6% |
Tobacco Industry Average Movement | 2.7% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.0% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: PHM7 has not had significant price volatility in the past 3 months.
Volatility Over Time: PHM7's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1822 | 6,400 | Billy Gifford | www.altria.com |
Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company offers cigarettes primarily under the Marlboro brand; large cigars and pipe tobacco under the Black & Mild brand; moist smokeless tobacco and snus products under the Copenhagen, Skoal, Red Seal, and Husky brands; oral nicotine pouches under the on! brand; and e-vapor products under the NJOY ACE brand.
Altria Group, Inc. Fundamentals Summary
PHM7 fundamental statistics | |
---|---|
Market cap | €66.32b |
Earnings (TTM) | €7.62b |
Revenue (TTM) | €19.26b |
8.7x
P/E Ratio3.5x
P/S RatioIs PHM7 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
PHM7 income statement (TTM) | |
---|---|
Revenue | US$20.50b |
Cost of Revenue | US$6.25b |
Gross Profit | US$14.26b |
Other Expenses | US$6.14b |
Earnings | US$8.11b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 25, 2024
Earnings per share (EPS) | 4.72 |
Gross Margin | 69.53% |
Net Profit Margin | 39.57% |
Debt/Equity Ratio | -751.7% |
How did PHM7 perform over the long term?
See historical performance and comparison